Entia Biosciences (ERGO) Stock Price & Analysis
ERGO Stock Chart & Stats
- Day’s Range
- $0.04 - $0.04
- 52-Week Range
- $0.04 - $0.04
- Previous Close
- $0.04
- Volume
- 100
- Average Volume (3M)
- 23
- Market Cap
- $33.66K
- Enterprise Value
- $980.05B
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- N/A
- Price to Earnings (P/E)
- ―
- Beta
- -68.62
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
ERGO FAQ
What was Entia Biosciences’s price range in the past 12 months?
What is Entia Biosciences’s market cap?
When is Entia Biosciences’s upcoming earnings report date?
Is Entia Biosciences overvalued?
Does Entia Biosciences pay dividends?
What is Entia Biosciences’s EPS estimate?
How many shares outstanding does Entia Biosciences have?
Which hedge fund is a major shareholder of Entia Biosciences?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Entia Biosciences
Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products in the United States. The company develops ErgoD2, a pharmaceutical grade organic compound for the improvement of iron homeostasis and mitigation of iron-related disorders presenting in anemia, chronic kidney disease, and select neurodegenerative diseases. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical food, nutraceuticals, cosmetics, and other products. In addition, the company offers beauty products under the GROH brand name. It markets its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was incorporated in 2007 and is headquartered in Sherwood, Oregon.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Timothy A. Timmins
- Employees
- 6
- Website
- www.roxanaradu.com
- Address
- 13565 SW Tualatin-Sherwood Road, Sherwood, OR, 97140, US
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 0 | 2 | 0 |
| Technical Analysis | 0 | 0 | 0 |
| Moving Averages | 0 | 2 | 0 |